The 3rd International Conference on Vaccines Research and Development (Vaccines R&D 2017) at the Sheraton Reston Hotel, Reston located within the Washington, D.C. metropolitan area, brought…
The 2nd International Conference on Vaccines Research and Development (Vaccines R&D 2016) in the beautiful Cartagena city brought together more than 250 experts of the leading…
Manuel Elkin Patarroyo Colfavac announced that the vaccine will be tested in humans in Africa. After 35 years of research, the Colombian scientist Manuel Elkin Patarroyo…
The first International Conference on Vaccines Research & Development (Vaccines R&D-2015) concluded successfully on November 04, 2015. The three-day conference organized by United Scientific Group (USG)…
GAITHERSBURG, Md., Nov. 4, 2015 /PRNewswire/ — GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced that Douglas E. Brough, Ph.D., the company’s chief scientific…
Gaithersburg, Md.—November 2, 2015 — VLP Therapeutics, LLC. (“VLP”), a Gaithersburg-based biotechnology company focusing on the research and development of therapeutic and preventative vaccines and next…
United Scientific Group is pleased to announce the groundbreaking lineup of keynote and featured speakers for Vaccines Research & Development Conference taking place during November 2-4,…